Catalyst Pharmaceutical CPRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $221.32M+12.1% | $214.33M+30.8% | $217.56M+52.4% | $208.67M+206% | $197.35M+203% | ||
| $330K-22.5% | $375K-5.5% | $417K+13.6% | $451K+31.9% | $426K+27.9% | ||
| $25.19M+26.9% | $24.78M+11.4% | $24.29M+13.9% | $23.04M+11.2% | $19.85M+1.3% | ||
| $208.21M-22.3% | $208.67M-13.0% | $234.66M+4.5% | $275.09M+39.8% | $267.93M+63.9% | ||
| $85K-76.2% | $58K-89.6% | $114K-79.7% | $373K+1.9% | $357K+0.3% | ||
| -$85K+76.2% | -$58K+89.6% | -$114K+99.7% | -$373K+99.7% | -$357K+99.7% | ||
| $33.55M+430% | $25.3M— | $18.98M— | $12.65M— | $6.33M— | ||
| -$32.93M-481% | -$16.99M-112% | $13.02M-90.8% | $8.37M-93.6% | $8.65M-93.3% | ||
| $175.2M-35.2% | $191.62M-49.6% | $247.56M— | $277.11M— | $270.25M— | ||
| $208.13M-22.2% | $208.61M-12.8% | $234.54M+4.7% | $274.72M+39.8% | $267.57M+64.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Catalyst Pharmaceutical generate?
- Catalyst Pharmaceutical (CPRX) generated $208.2M in operating cash flow over the trailing twelve months.
- What is Catalyst Pharmaceutical's free cash flow?
- After $85.0K of capital expenditures, Catalyst Pharmaceutical's free cash flow was $208.1M over the trailing twelve months, down 22.2% year over year.
- Where does Catalyst Pharmaceutical's cash flow data come from?
- Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
